URGN CLASS ACTION NOTICE: UroGen Pharma Ltd. Was Sued For Securities Fraud; Contact BFA Law if You Suffered Losses

  • NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against UroGen Pharma Ltd. (NASDAQ:URGN) and certain of the Company's senior executives for potential violations of the federal securities laws.